Rezulin (troglitazone) for Type II diabetes
March 1997
Rezulin (troglitazone) for Type II diabetes will be out soon. Parke-Davis is launching it this month in the U.S...possibly later this year in Canada.
This is the first drug in a new class...called "glitazones." These drugs are very useful...they reduce insulin resistance.
Troglitazone stimulates the uptake of glucose into skeletal muscle cells...and decreases glucose production in the liver.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 300+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive